The in situ inflammatory profile of lymphocutaneous and fixed forms of human sporotrichosis

Medical Mycology

Volumn 49, Issue 6, 2011, Pages 612-620

  Morgado, Fernanda N ^a,b   Schubach, Armando O ^b   Barros, Mã́nica B L ^b   Conceição Silva, Fátima ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Fixed cutaneous sporotrichosis; Immunohistochemistry; Lymphocutaneous sporotrichosis; NET; Skin immune system; Sporothrix schenckii

Indexed keywords

CD22 ANTIGEN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS LIGAND; GRANZYME B; INDUCIBLE NITRIC OXIDE SYNTHASE; KI 67 ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; ARTICLE; CD22+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FIXED CUTANEOUS SPOROTRICHOSIS; FUNGAL CELL; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY INFILTRATE; LANGERHANS CELL; LYMPHOCUTANEOUS SPOROTRICHOSIS; LYMPHOCYTE; MACROPHAGE; MALE; NEUTROPHIL; NUCLEIC ACID ANALYSIS; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN DEFECT; SPOROTRICHOSIS; T LYMPHOCYTE; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD22; CD4-POSITIVE T-LYMPHOCYTES; COLONY COUNT, MICROBIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; NEUTROPHILS; SPOROTRICHOSIS; YOUNG ADULT;

SPOROTHRIX SCHENCKII;

EID: 79960455312     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.552532     Document Type: Article

References (28)

1. Kauffman CA. Sporotrichosis. Clin Infect Dis 1999; 29: 231-236.
2. Chapman SW, Daniel CR. Cutaneous manifestations of fungal infection. Infect Dis Clin North Am 1994; 8: 879-910.
3. Barros MBL, Schubach AO, do Valle ACF, et al. Cat-transmitted sporotrichosis epidemic in Rio de Janeiro, Brazil: description of a series of cases. Clin Infect Dis 2004; 38: 529-535.
4. Schubach TM, Valle AC, Gutierrez-Galhardo MC, et al. Isolation of Sporothrix schenckii from the nails of domestic cats (Felis catus). Med Mycol 2001; 39: 147-149. (Pubitemid 32192932)
5. Schubach TMP, Schubach AO, Okamoto T, et al. Evaluation of an epidemic of sporotrichosis in cats: 347 cases (1998-2001). J Am Vet Med Assoc 2004;224: 1623-1629. (Pubitemid 38621444)
6. Schubach AO, Barros MBL, Wanke B. Epidemic sporotrichosis. Curr Opin Infect Dis 2008, 21: 129-133. (Pubitemid 351641514)
7. Lopes-Bezerra LM, Schubach AO, Costa RO. Sporothrix schenckii and sporotrichosis. An Acad Bras Cienc 2006; 78: 293-308. (Pubitemid 43764836)
8. Lüder CG, Gross U, Lopes MF. Intracellular protozoan parasites and apoptosis: diverse strategies to modulate parasite-host interactions. Trends Parasitol 2001; 17: 480-486. (Pubitemid 32918267)
9. Lüder CGK, Gross U. Apoptosis and its modulation during infection with Toxoplasma gondii: molecular mechanisms and role in patho-genesis. Curr Top Microbiol Immunol 2005; 289: 219-237. (Pubitemid 40283465)
10. Murray PJ. Def ning the requirements for immunological control of mycobacterial infections. Trends Microbiol 1999; 7: 366-372. (Pubitemid 29421662)
11. Brito MMS, Conceição-Silva F, Morgado FN, et al. Comparison of virulence of different Sporothrix schenckii clinical isolates using experimental murine model. Med Mycol 2007; 45: 721-729. (Pubitemid 350153964)
12. Neyra E, Fonteyne P, Swinne D, et al. Epidemiology of human sporotrichosis investigated by amplif ed fragment length polymorphism. J Clin Microbiol 2005; 43: 1348-1352. (Pubitemid 40364960)
13. Uenotsuchi T, Takeuchi S, Matsuda T, et al. Differential induction of Th1-prone immunity by human dendritic cells activated with Sporothrix schenckii of cutaneous and visceral origins to determine their different virulence. Int Immunol 2006; 18: 1637-1646. (Pubitemid 44884026)
14. Nobre MDO, Antunes TDA, de Faria RO, et al. Differences in virulence between isolates of feline Sporotrichosis. Mycopathologia 2005; 160: 43-49. (Pubitemid 41298140)
15. Dickerson CL, Taylor RL, Drutz DJ. Susceptibility of congenitally athy-mic (nude) mice to sporotrichosis. Infect Immun 1983; 40: 417-420. (Pubitemid 13163084)
16. Shiraishi A, Nakagaki K, Arai T. Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 1992; 120: 15-21.
17. Tachibana T, Matsuyama T, Mtsuyama M. Involvement of CD4 + T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999; 37: 397-404. (Pubitemid 30006562)
18. Kajiwara H, Saito M, Ohga S, et al. Impaired host defense against Sporothrix schenckii in mice with chronic granulomatous disease. Infect Immun 2004; 72: 5073-5079. (Pubitemid 39223391)
19. Morgado FN, Schubach AO, Rosalino CMV, et al. Is the in situ inf ammatory reaction an important tool to understand the cellular immune response in American tegumentary leishmaniasis? Br J Dermatol 2008; 158: 50-58. (Pubitemid 350225549)
20. Carlos IZ, Sassá MF, da Graça Sgarbi DB, et al. Current research on the immune response to experimental sporotrichosis. Mycopathologia 2009; 168: 1-10.
21. Galhardo MCG, De Oliveira RMZ, do Valle ACF, et al. Molecular epidemiology and antifungal susceptibility patterns of Sporothrix schenckii isolates from a cat-transmitted epidemic of sporotrichosis in Rio de Janeiro, Brazil. Med Mycol 2008; 46: 141-151. (Pubitemid 351372333)
22. Cunningham KM, Bulmer GS, Rhoades ER. Phagocytosis and intracellular fate of Sporothrix schenckii. J Infect Dis 1979; 140: 815-817. (Pubitemid 10214210)
23. Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science 2004; 3: 1532-1535. (Pubitemid 38314426)
24. Baker VS, Imade GE, Molta NB, et al. Cytokine-associated neutrophil extracellular traps and antinuclear antibodies in Plasmodium falciparum infected children under six years of age. Malar J 2008; 7: 41.
25. Guimarães-Costa AB, Nascimento MTC, Froment GS, et al. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps. Proc Natl Acad Sci USA 2009; 106: 6748-6753.
26. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343: 37-49. (Pubitemid 30447991)
27. Carlos IZ, Sgarbi DBG, Santos GC, Placeres MCP. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand J Immunol 2003; 57: 214-220. (Pubitemid 36356813)
28. Fernandes KS, Coelho AL, Lopes Bezerra LM, Barja-Fidalgo C. Virulence of Sporothrix schenckii conidia and yeast cells, and their susceptibility to nitric oxide. Immunology 2000; 101: 563-569. (Pubitemid 32001472)